Meta-analysis of the association between chromosomal polymorphisms and outcomes of embryo transfer following in vitro fertilization and/or intracytoplasmic sperm injection.
The outcomes of in vitro fertilization and/or intracytoplasmic sperm injection (IVF/ICSI) are contradictory among individuals with chromosomal polymorphisms. To assess whether chromosomal polymorphisms affect the outcomes of assisted reproductive technologies. Four online databases were searched from inception to September 18, 2017, using terms including "chromosomal polymorphisms" and "In vitro fertilization." The meta-analysis included studies published in any language on IVF/ICSI outcomes in relation to male and/or female chromosomal polymorphisms (n=8). Data were extracted using a predesigned form. The IVF/ICSI outcomes were then pooled and their heterogeneity assessed. Male chromosomal polymorphisms showed lowered values for fertilization rate (odds ratio [OR] 1.29, 95% confidence interval [CI] 1.09-1.54; P=0.004); cleavage rate (OR 2.65, 95% CI 1.88-3.72; P<0.001); good quality embryos rate (OR 1.26, 95% CI 1.15-1.39; P<0.001); and live birth rate (OR 1.42, 95% CI 1.10-1.83; P=0.007). By contrast, early spontaneous abortion rate, clinical pregnancy rate, and ongoing pregnancy rate were not affected in this group. No relationship was found between IVF/ICSI outcomes and female chromosomal polymorphisms. Male, but not female, chromosomal polymorphisms were associated with lowered values for some outcomes of IVF/ICSI.